May 2026 Aesthetic Medicine Update: A Neurotoxin Market in Motion
June 2, 2026
The May 2026 aesthetic medicine update covers a neurotoxin pipeline producing genuinely new options and a patient population that is outgrowing the standard consult model. Providers who act on this month’s clinical and business signals — from GLP-1 protocol updates to the growing male aesthetic market — will be better positioned heading into the second half of 2026.